Artwork

Content provided by MTPConnect. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MTPConnect or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

VitalTrace: Revolutionising Childbirth Monitoring to Keep Mothers and Babies Safe

17:41
 
Share
 

Manage episode 423489039 series 3009792
Content provided by MTPConnect. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MTPConnect or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The Clinical Translation and Commercialisation Medtech (CTCM) program aims to boost commercialisation of home-grown medical products. It is delivered by MTPConnect on behalf of the Medical Research Future Fund.

WA-based VitalTrace is one of the companies participating in the CTCM program and developing a groundbreaking medical device to revolutionise fetal monitoring during childbirth. The company has set up an Australian-based manufacturing facility, received FDA Breakthrough device designation and will soon start its first clinical trial with mothers and babies.

Joining host Caroline Duell on the podcast is Dr Chuong Phan, VitalTrace’s Manufacturing Lead, to share more about the progress and translation of DelivAssure, a unique biosensor innovation.

This episode comes to you from a special medtech event held in Melbourne and hosted by MTPConnect’s CTCM program and QUT’s The BridgeTech Program. The Design to Manufacturing Tours brought together a number of medtech startups to visit some of Australia’s leading medical manufacturing operations.

  continue reading

176 episodes

Artwork
iconShare
 
Manage episode 423489039 series 3009792
Content provided by MTPConnect. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MTPConnect or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The Clinical Translation and Commercialisation Medtech (CTCM) program aims to boost commercialisation of home-grown medical products. It is delivered by MTPConnect on behalf of the Medical Research Future Fund.

WA-based VitalTrace is one of the companies participating in the CTCM program and developing a groundbreaking medical device to revolutionise fetal monitoring during childbirth. The company has set up an Australian-based manufacturing facility, received FDA Breakthrough device designation and will soon start its first clinical trial with mothers and babies.

Joining host Caroline Duell on the podcast is Dr Chuong Phan, VitalTrace’s Manufacturing Lead, to share more about the progress and translation of DelivAssure, a unique biosensor innovation.

This episode comes to you from a special medtech event held in Melbourne and hosted by MTPConnect’s CTCM program and QUT’s The BridgeTech Program. The Design to Manufacturing Tours brought together a number of medtech startups to visit some of Australia’s leading medical manufacturing operations.

  continue reading

176 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide